|
|
 |
|
Viewing report
|
|
|
|
Sleeping Pills - Global Strategic Business Report
Global Industry Analysts, Inc., Aug 2010, Pages: 354
This report analyzes the Global market for Sleeping Pills in US$ Million. Annual estimates and forecasts are provided for the period of 2007 through 2015. Also, a six-year historic analysis is provided for this market. The report profiles 34 companies including many key and niche players such as Actelion Pharmaceuticals Ltd., Abbott India Limited, Apotex Inc., Aurobindo Pharma Limited, Caraco Pharmaceutical Laboratories, Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, King Pharmaceuticals Inc., Neurocrine Biosciences, Ranbaxy Laboratories Limited, Roxane Laboratories, Inc., Sepracor Inc ., Sanofi-aventis, Somaxon Pharmaceuticals Inc., Synthon BV, Takeda Pharmaceutical Company Limited, and Transcept Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt
Allergy Drugs - Global Strategic Business Report
Prescription Drugs - Global Strategic Business Report
Insomnia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
CNS Therapeutics - Global Strategic Business Report
Anti-Hypertensive Drugs - Global Strategic Business Report
Bipolar Disorder - Global Strategic Business Report
Tinea Pedis (Athletes Foot) - Global Strategic Business Report
Chronic Obstructive Pulmonary Disease - Global Strategic Business Report
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
|
|
|
|
